Diabetes Mellitus: Perguntas & Respostas Online (Diabetes Mellitus: Question & Answers)

■ Unrecognised cardiovascular disease in type 2 diabetes: Is it time to act earlier?

Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova et al

Cardiovasc Diabetol. 2018; 17: 145

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247507/

■ Is ischemia the only predicting cardiovascular outcomes in all diabetes mellitus patients?

Mark W. Kennedy, Enrico Fabris, Harry Suryapranata, Elvin Kedhi

Cardiovasc Diabetol. 2017; 16: 51

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397766/

■ How do we know that statins are diabeteogenic, and why? Is it an import issue in the clinical practice?

Cybulska B, Kłosiewicz-Latoszek L.

Kardiol Pol. 2018;76(8):1217-1223

https://ojs.kardiologiapolska.pl/kp/article/view/KP.a2018.0150/9886

■ Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: Does really matter?

Alexander Tenenbaum, Enrique Z. Fisman

Cardiovasc Diabetol. 2018; 17: 119

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112138/

■ Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?

Peizhu Chen, Xuhong Hou, Gang Hu et al

Cardiovasc Diabetol. 2018; 17: 93

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020307/

■ Excess BMI in childhood: A modifiable risk fator for type 1diabetes development?

Christine Therese Ferrara, Susan Michelle Geyer, Yuk-Fun Liu et al

the Type 1 Diabetes TrialNet Study Group

Diabetes Care. 2017 May; 40(5): 698–701

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399656/

■ Does glucagon have a positive inotropic effect in the human heart?

Jesus Hernández-Cascales

Cardiovasc Diabetol. 2018; 17: 148.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258156/

■ Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?

Tuzun, Dilek et al.

Arch. Endocrinol. Metab., Oct 2018, vol.62, no.5, p.506-513

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000500506&lng=en&nrm=iso

■ Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?

Kizilgul, Muhammed et al.

Arch. Endocrinol. Metab., Dec 2017, vol.61, no.6, p.562-566

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000600562&lng=en&nrm=iso

■ Tight or less tight glycaemic targets for women with gestational mellitus for reducing maternal and perinatal morbidity? (TARGET): study protocol for a stepped wedge randomised trial

Crowther CA, Alsweiler JM, Hughes R, Brown J;

Target Study Group.

BMC Pregnancy Childbirth. 2018 Oct 29;18(1):425

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206938/

■ Identifying risk for type 2 diabetes in different age cohorts: Does one size fit all?

Maria L Alva, Thomas J Hoerger, Ping Zhang, Edward W Gregg

BMJ Open Diabetes Res Care. 2017; 5(1): e000447

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663261/

■ Neurodegeneration in diabetic retinopathy: Does it really matter?

Rafael Simó, Alan W. Stitt, Thomas W. Gardner

Diabetologia. Vol 61(9): 1902–1912

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096638/

■ Is it time to change the type 2 diabetes treatment paradigm? Yes! GLP-1 RAs should replace metformin in the type 2 diabetes alg0rithm

Muhammad Abdul-Ghani, Ralph A. DeFronzo

Diabetes Care. 2017 Aug; 40(8): 1121–1127

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521981/

■ Declines in incidence od diabetes in the U.S. – Real Progresso or Artifact?

Elizabeth Selvin, Mohammed K. Ali

Diabetes Care. 2017 Sep; 40(9): 1139–1143

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566279/

■ Mediators of diabetic neuropathy – Is hyperglycemia the only culprit?

A Grisold, B C Callaghan, E L Feldman

Curr Opin Endocrinol Diabetes Obes2017,vol24 (2): 103-111

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831542/

■ How similar are biosimilar? What do clinicians need to know about biosimilar and follow-on insulins?

Curtis Triplitt, Debbie Hinnen, Virginia Valentine

Clin Diabetes. 2017 Oct; 35(4): 209–216

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669137/

■ Does metformin exposure before ICU stay have any impact on patients´s outcome? A retrospective cohort study of diabetic patients

Sebastien Jochmans, Jean-Emmanuel Alphonsine, Jonathan Chelly et al

Ann Intensive Care. 2017; 7: 116

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712297/

■ How´s your sugar? Evaluation of a website for aboriginal people with diabetes

Karen Adams, Anna Liebzeit, Jennifer Browne, Petah Atkinson

JMIR Diabetes. 2017 Jan-Jun; 2(1): e6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238832/

■ Update on the impact, diagnosis, and management of cardiovascular autonomic neuropathy in diabetes: What is defined? What is new?, and What is unmet

Vincenza Spallone

Diabetes Metab J. 2019 Feb; 43(1): 3–30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387879/

■ Can reducing sitting time in the university setting improve the cardiometabolic health of college students?

Karrie M Butler, Joyce S Ramos, Christina A Buchanan, Lance C Dalleck

Diabetes Metab Syndr Obes. 2018; 11: 603–610

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181072/

■ Is there an association between liraglutide use and female breast câncer in a real-world setting?

Donnie Funch, Kathleen Mortimer, Ling Li, et al

Diabetes Metab Syndr Obes. 2018; 11: 791–806

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254592/

■ Is surgical debridement necessary in the diabetic foot treated with photodynamic therapy?